Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Must Reads by Date

Must reads for theWeek ending June 7, 2020

Huntington's disease biomarkers appear 24 years before clinical symptoms,

COVID-19-related inflammatory condition more common in black children in small study,

Telerehabilitation may be effective in MS,

More must reads

Must reads for theWeek ending May 31, 2020

COVID-19 may increase risk of preterm birth and cesarean delivery,

Nilotinib is safe in moderate and advanced Parkinson’s disease,

Placental injury reported in women with COVID-19,

SARS-CoV-2 infection rate 16% in asymptomatic pregnant women at delivery,

Mixed results for aducanumab in two phase 3 trials for Alzheimer’s disease,

More must reads

Must reads for theWeek ending May 24, 2020

Chronic migraine: Multiple cranial nerve blocks may be an effective prevention therapy,

IV eptinezumab cuts migraine days over 12 weeks,

Cognitive impairment prevalent in chronic migraine,

Subcutaneous sumatriptan eases cilostazol-induced headache in patients with migraine,

As visits for AMI drop during pandemic, deaths rise,

More must reads

Must reads for theWeek ending May 17, 2020

Yoga is a good adjunct to migraine therapy,

Satralizumab monotherapy reduces NMOSD relapse rate,

Bronchoscopy guideline for COVID-19 pandemic: Use sparingly,

Updated AAN advisory outlines when PFO closure may be option for patients with stroke,

Triple-antiviral combo speeds COVID-19 recovery,

More must reads

Must reads for theWeek ending May 10, 2020

Novel inflammatory syndrome in children possibly linked to COVID-19,

Patients with epilepsy may underreport seizures, survey finds,

Memory tests in 50s predict mild cognitive impairment in middle age,

Two-thirds of American adults are cognitively impaired at age 70,

Alzheimer’s disease patients may benefit from new biomarkers,

More must reads

Pages